Condition
Fluconazole
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07557966Not ApplicableCompleted
Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis
NCT05775692UnknownPrimary
Population Pharmacokinetics of Fluconazole in the Treatment of Neonatal Fungal Infectious Disease
NCT04122560Phase 4CompletedPrimary
Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration
NCT00309582Completed
Nevirapine Levels and Fluconazole
Showing all 4 trials